成田　朋子　 (ナリタ　トモコ)

研究者情報

J-Global ID

• 201701007973797501

研究分野

• その他 / その他

研究活動情報

論文

• Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

  Tomotaka Suzuki; Keiichiro Fujii; Naohiro Matsunaga; Hirokazu Sasaki; Takashi Kanamori; Arisa Asano; Shiori Kinoshita; Tomoko Narita; Ayako Masaki; Takaomi Sanda; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida; Hiroshi Inagaki

  British journal of haematology 2025年04月
• Clinical Significance of Cytomegalovirus Reactivation in Patients With Plasma Cell Dyscrasia Who Were Treated With Anti-CD38 Monoclonal Antibody: A Retrospective Analysis in a Single Institution.

  Naohiro Matsunaga; Tomotaka Suzuki; Nozomi Nishitarumizu; Yoko Nakanishi; Aki Kondo; Yukiyasu Kato; Toru Ebina; Yoshiaki Marumo; Tomoyuki Nakamura; Takahiro Nakashima; Shiori Kinoshita; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida

  Clinical lymphoma, myeloma & leukemia 24 8 531 - 536 2024年08月
• Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasone

  Takuto Tachita; Masaki Ri; Sho Aoki; Arisa Asano; Takashi Kanamori; Haruhito Totani; Shiori Kinoshita; Yu Asao; Tomoko Narita; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Hirokazu Komatsu; Shinsuke Iida

  Cancer Medicine 2024年07月 [査読有り]
  
• Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy

  Takahiro Nakashima; Shigeru Kusumoto; Takashi Ishida; Chie Kato; Shinya Hagiwara; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Hiroshi Inagaki; Yasuhito Tanaka; Shinsuke Iida

  Hepatology Research 2024年05月
• 骨髄腫治療における、有害事象によるカルフィルゾミブ早期中止

  海老名 徹; 鈴木 智貴; 西垂水 希美; 近藤 明希; 中西 陽子; 加藤 佑希康; 松永 尚大; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 85回 642 - 642 2023年10月
• 悪性リンパ腫に合併した自己免疫性溶血性貧血の13例についての検討

  西垂水 希美; 鈴木 智貴; 近藤 明希; 中西 陽子; 加藤 佑希康; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 正木 彩子; 李 正樹; 楠本 茂; 小松 弘和; 稲垣 宏; 飯田 真介

  日本血液学会学術集会 85回 1210 - 1210 2023年10月
• 初診時に末梢血の形質細胞比率が5-19%であった多発性骨髄腫患者の生存期間および臨床的特徴の解析

  中西 陽子; 鈴木 智貴; 橋本 大哉; 西垂水 希美; 近藤 明希; 加藤 佑希康; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 85回 1355 - 1355 2023年10月
• Simplified frailty scaleにおけるfrail患者のさらなる層別化

  加藤 佑希康; 鈴木 智貴; 橋本 大哉; 西垂水 希美; 近藤 明希; 中西 陽子; 松永 尚大; 海老名 徹; 丸茂 義晃; 浅野 有彩; 木下 史緒理; 成田 朋子; 李 政樹; 楠本 茂; 小松 弘和; 飯田 真介

  日本血液学会学術集会 85回 1533 - 1533 2023年10月
• Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

  Tomotaka Suzuki; Shigeru Kusumoto; Yoshiko Kamezaki; Hiroya Hashimoto; Nozomi Nishitarumizu; Yoko Nakanishi; Yukiyasu Kato; Akimi Kawai; Naohiro Matsunaga; Toru Ebina; Tomoyuki Nakamura; Yoshiaki Marumo; Kana Oiwa; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Atsushi Inagaki; Masaki Ri; Hirokazu Komatsu; Takashi Aritsu; Shinsuke Iida

  Cancer medicine 2023年04月
• A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.

  Tomotaka Suzuki; Shigeru Kusumoto; Yoshiko Kamezaki; Hiroya Hashimoto; Nozomi Nishitarumizu; Yoko Nakanishi; Yukiyasu Kato; Akimi Kawai; Naohiro Matsunaga; Toru Ebina; Tomoyuki Nakamura; Yoshiaki Marumo; Kana Oiwa; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Atsushi Inagaki; Masaki Ri; Hirokazu Komatsu; Takashi Aritsu; Shinsuke Iida

  International journal of hematology 1 - 10 2023年02月
• Recurrent pain attacks during romiplostim treatment in a patient with ITP carrying a heterozygous MEFV mutation.

  Shiori Kinoshita; Hirokazu Komatsu; Haruna Fujinami; Takashi Yoshida; Tomotaka Suzuki; Tomoko Narita; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Shinsuke Iida

  International journal of hematology 117 2 283 - 286 2023年02月
• Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features.

  Tomotaka Suzuki; Rui Yokomori; Takaomi Sanda; Takaki Kikuchi; Yoshiaki Marumo; Shiori Kinoshita; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  Frontiers in oncology 13 1116418 - 1116418 2023年
• Aberrant tryptophan metabolism leads to unfavorable outcomes in lenalidomide‐treated myeloma patients

  Arisa Asano; Masaki Ri; Ayako Masaki; Yasuhiro Maeda; Takuto Tachita; Kentaro Hirade; Yoshiaki Marumo; Takahiro Nakashima; Shinya Hagiwara; Shiori Kinoshita; Tomotaka Suzuki; Tomoko Narita; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  Hematological Oncology 2022年12月
• Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core-related antigen assay.

  Shinya Hagiwara; Shigeru Kusumoto; Takako Inoue; Shintaro Ogawa; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Takanori Suzuki; Kentaro Matsuura; Shintaro Yagi; Atsushi Kaneko; Katsumi Aoyagi; Shinsuke Iida; Yasuhito Tanaka

  Hepatology research : the official journal of the Japan Society of Hepatology 2022年02月
• Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma.

  Shuji Ozaki; Hiroshi Handa; Hiromi Koiso; Takayuki Saitoh; Kazutaka Sunami; Tadao Ishida; Kenshi Suzuki; Tomoko Narita; Shinsuke Iida; Yuichi Nakamura; Kazuhito Suzuki; Noriko Nishimura; Hirokazu Murakami; Kazuyuki Shimizu

  Journal of cancer research and clinical oncology 2021年06月
• 多発性骨髄腫の継続・維持療法の有効性に関する傾向スコアマッチング解析(Propensity-score matched analysis of the efficacy of maintenance or continuous therapy on multiple myeloma)

  尾崎 修治; 半田 寛; 小磯 博美; 齋藤 貴之; 角南 一貴; 石田 禎夫; 鈴木 憲史; 成田 朋子; 飯田 真介; 中村 裕一; 鈴木 一史; 西村 倫子; 村上 博和; 清水 一之

  International Journal of Myeloma 11 2 96 - 96 2021年05月
• Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.

  Takashi Kanamori; Masashi Sanada; Masaki Ri; Hiroo Ueno; Dai Nishijima; Takahiko Yasuda; Takuto Tachita; Tomoko Narita; Shigeru Kusumoto; Atsushi Inagaki; Rei Ishihara; Yuki Murakami; Nobuhiko Kobayashi; Yusuke Shiozawa; Kenichi Yoshida; Masahiro M Nakagawa; Yasuhito Nannya; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Keizo Horibe; Hiroshi Handa; Seishi Ogawa; Shinsuke Iida

  British journal of haematology 191 5 755 - 763 2020年12月
• Clinical significance of tryptophan catabolism in follicular lymphoma.

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Asahi Ito; Susumu Suzuki; Tomoko Narita; Shiori Kinoshita; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Ryuzo Ueda; Ilseung Choi; Youko Suehiro; Shinsuke Iida

  Hematological oncology 38 5 742 - 753 2020年12月
• Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational study.

  Takafumi Nakayama; Yoshiko Oshima; Shigeru Kusumoto; Junki Yamamoto; Satoshi Osaga; Haruna Fujinami; Takaki Kikuchi; Tomotaka Suzuki; Haruhito Totani; Shiori Kinoshita; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Kazuaki Wakami; Toshihiko Goto; Tomonori Sugiura; Yoshihiro Seo; Nobuyuki Ohte; Shinsuke Iida

  EJHaem 1 2 498 - 506 2020年11月
• Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy.

  Takaki Kikuchi; Shigeru Kusumoto; Yasuhito Tanaka; Yoshiko Oshima; Haruna Fujinami; Tomotaka Suzuki; Haruhito Totani; Shiori Kinoshita; Yu Asao; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Shinsuke Iida

  Journal of clinical and experimental hematopathology : JCEH 60 2 51 - 54 2020年06月
• Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma.

  Murase T; Ri M; Narita T; Fujii K; Masaki A; Iida S; Inagaki H

  Cancer science 110 8 2600 - 2606 2019年08月 [査読有り]
  
• Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.

  Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H

  Journal of clinical and experimental hematopathology : JCEH 2019年08月 [査読有り]
  
• Exophiala dermatitidis Fungemia Diagnosed Using Time-of-flight Mass Spectrometry during Chemotherapy for Malignant Lymphoma and Successful Treatment with Voriconazole.

  Takashi Yoshida; Takuto Tachita; Haruna Fujinami; Yoshiko Oshima; Hirokazu Sasaki; Yoshiaki Marumo; Tomoko Narita; Asahi Ito; Masaki Ri; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Internal medicine (Tokyo, Japan) 58 15 2219 - 2224 2019年08月 [査読有り]
  
• Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.

  Takashi Yoshida; Masaki Ri; Haruna Fujinami; Yoshiko Oshima; Takuto Tachita; Yoshiaki Marumo; Hirokazu Sasaki; Shiori Kinoshita; Haruhito Totani; Tomoko Narita; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  International journal of hematology 110 2 228 - 236 2019年08月 [査読有り]
  
• Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantation.

  Hirokazu Sasaki; Sachiko Mitani; Shigeru Kusumoto; Yoshiaki Marumo; Arisa Asano; Takashi Yoshida; Tomoko Narita; Asahi Ito; Hiroki Yano; Masaki Ri; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  International journal of hematology 110 1 119 - 123 2019年07月 [査読有り]
  
• Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma.

  Reham Ashour; Masaki Ri; Sanaa Shaker Aly; Takashi Yoshida; Takuto Tachita; Takashi Kanamori; Sho Aoki; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Hirokazu Komatsu; Samar Mansour; Abdelrahman A Elsaied; Shinsuke Iida

  International journal of hematology 110 1 69 - 76 2019年07月 [査読有り]
  
• Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

  Hiroyuki Takamatsu; Takeshi Yamashita; Shingo Kurahashi; Takayuki Saitoh; Tadakazu Kondo; Takeshi Maeda; Hideyuki Nakazawa; Makoto Murata; Tomoko Narita; Junya Kuroda; Hisako Hashimoto; Koji Kawamura; Toshihiro Miyamoto; Sumihisa Honda; Tatsuo Ichinohe; Yoshiko Atsuta; Kazutaka Sunami

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 25 3 474 - 479 2019年03月 [査読有り]
  
• [Richter syndrome successfully treated with ibrutinib monotherapy: two case reports].

  Haruna Fujinami; Shigeru Kusumoto; Ayako Masaki; Yoshiko Ohshima; Takuto Tachita; Hirokazu Sasaki; Yoshiaki Marumo; Takashi Yoshida; Tomoko Narita; Asahi Ito; Masaki Ri; Hirokazu Komatsu; Hiroshi Inagaki; Shinsuke Iida

  [Rinsho ketsueki] The Japanese journal of clinical hematology 60 10 1462 - 1467 2019年 [査読有り]
  
• Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.

  Masaki A; Ishida T; Suzuki S; Ito A; Narita T; Kinoshita S; Ri M; Kusumoto S; Komatsu H; Inagaki H; Ueda R; Iida S

  Cancer science 109 8 2383 - 2390 2018年08月 [査読有り]
  
• Cyclin-dependent kinase 9 as a potential specific molecular target in NK cell leukemia/lymphoma.

  Kinoshita S; Ishida T; Ito A; Narita T; Masaki A; Suzuki S; Yoshida T; Ri M; Kusumoto S; Komatsu H; Shimizu N; Inagaki H; Kuroda T; Scholz A; Ueda R; Sanda T; Iida S

  Haematologica 103 12 2059 - 2068 2018年08月 [査読有り]
  
• Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer.

  Izumida K; Kaneko A; Takahashi K; Kusumoto S; Narita T; Takami A; Iida S; Aoyagi K; Tanaka Y

  Hepatology research : the official journal of the Japan Society of Hepatology 48 13 1081 - 1091 2018年07月 [査読有り]
  
• Potent antitumor effect of combination therapy with sub-optimal doses of akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma

  Shiori Kinoshita; Masaki Ri; Takashi Kanamori; Sho Aoki; Takashi Yoshida; Tomoko Narita; Haruhito Totani; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Oncology Letters 15 6 9450 - 9456 2018年06月 [査読有り]
  
• Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

  Takashi Yoshida; Masaki Ri; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Reham Ashour; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  PLoS ONE 13 5 e0196780  2018年05月 [査読有り]
  
• Clinical significance of tryptophan catabolism in Hodgkin lymphoma

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Asahi Ito; Susumu Suzuki; Tomoko Narita; Shiori Kinoshita; Hisashi Takino; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Hiroshi Inagaki; Ryuzo Ueda; Ilseung Choi; Youko Suehiro; Shinsuke Iida

  Cancer Science 109 1 74 - 83 2018年01月 [査読有り]
  
• [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].

  Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S

  [Rinsho ketsueki] The Japanese journal of clinical hematology 59 2 161 - 166 2018年 [査読有り]
  
• Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits.

  Yoshida T; Ri M; Kanamori T; Aoki S; Ashour R; Kinoshita S; Narita T; Totani H; Masaki A; Ito A; Kusumoto S; Ishida T; Komatsu H; Kitahata S; Chiba T; Ichikawa S; Iida S

  Oncotarget 9 11 9975 - 9991 2018年 [査読有り]
  
• [Thrombosis in multiple myeloma].

  Narita T

  [Rinsho ketsueki] The Japanese journal of clinical hematology 59 8 1027 - 1033 2018年 [査読有り]
  
• Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma

  Shotaro Tatekawa; Yoshiaki Chinen; Masaki Ri; Tomoko Narita; Yuji Shimura; Yayoi Matsumura-Kimoto; Taku Tsukamoto; Tsutomu Kobayashi; Eri Kawata; Nobuhiko Uoshima; Tomohiko Taki; Masafumi Taniwaki; Hiroshi Handa; Shinsuke Iida; Junya Kuroda

  BRITISH JOURNAL OF HAEMATOLOGY 178 4 534 - 546 2017年08月 [査読有り]
  
• Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

  Tomoko Narita; Takashi Ishida; Asahi Ito; Ayako Masaki; Shiori Kinoshita; Susumu Suzuki; Hisashi Takino; Takashi Yoshida; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Kazunori Imada; Yuetsu Tanaka; Akifumi Takaori-Kondo; Hiroshi Inagaki; Arne Scholz; Philip Lienau; Taruho Kuroda; Ryuzo Ueda; Shinsuke Iida

  BLOOD 130 9 1114 - 1124 2017年08月 [査読有り]
  
• POEMS症候群との鑑別に苦慮したM蛋白を伴う成人発症型ネマリンミオパチーの1例

  金森 貴之; 楠本 茂; 萩原 真也; 加藤 千絵; 中島 貴裕; 村上 五月; 成田 朋子; 伊藤 旭; 李 政樹; 石田 高司; 小松 弘和; 飯田 真介; 大喜多 賢治; 松川 則之

  臨床血液 58 6 684 - 685 (一社)日本血液学会-東京事務局 2017年06月
• Anti-Myeloma Activity of a Syringolin Analog: A Dual 20S Proteasome Inhibitor of Beta 2 and 5 Subunits

  Takashi Yoshida; Masaki Ri; Shiori Kinoshita; Tomoko Narita; Haruhito Totani; Reham Ashour; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Satoshi Ichikawa; Shinsuke Iida

  BLOOD 128 22 2016年12月 [査読有り]
  
• EBV関連T細胞およびNK細胞リンパ増殖性疾患の治療標的としてのCDK9(CDK9 as a target for treatment in EBV-associated T- and NK-cell lymphoproliferative diseases)

  Kinoshita Shiori; Ishida Takashi; Narita Tomoko; Ito Asahi; Masaki Ayako; Suzuki Susumu; Takino Hisashi; Yoshida Takashi; Ri Masaki; Kusumoto Shigeru; Komatsu Hirokazu; Shimizu Norio; Inagaki Hiroshi; Scholz Arne; Ince Stuart; Ueda Ryuzo; Iida Shinsuke

  臨床血液 57 9 1541 - 1541 (一社)日本血液学会-東京事務局 2016年09月 [査読有り]
  
• Phase I study of once weekly treatment with bortezomib in combination with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma

  Haruhito Totani; Masaki Ri; Chie Kato; Takahiro Nakashima; Nana Suzuki; Shinya Hagiwara; Takashi Kanamori; Satsuki Murakami; Arisa Masuda; Shiori Kinoshita; Takashi Yoshida; Tomoko Narita; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  INTERNATIONAL JOURNAL OF HEMATOLOGY 103 3 316 - 321 2016年03月 [査読有り]
  
• Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.

  Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S

  Blood Cancer J. 2015 Dec 4;5:e373. 2015年12月 [査読有り]
  
• Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells

  Shohei Mizuno; Ichiro Hanamura; Akinobu Ota; Sivasundaram Karnan; Tomoko Narita; Masaki Ri; Motonori Mizutani; Mineaki Goto; Mayuko Gotou; Norikazu Tsunekawa; Masato Shikami; Shinsuke Iida; Yoshitaka Hosokawa; Hiroshi Miwa; Ryuzo Ueda; Masakazu Nitta; Akiyoshi Takami

  INTERNATIONAL JOURNAL OF HEMATOLOGY 102 5 569 - 578 2015年11月 [査読有り]
  
• [Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma].

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Susumu Suzuki; Asahi Ito; Hisashi Takino; Haruhito Totani; Takashi Yoshida; Shiori Kinoshita; Hiroka Ogura; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Atsushi Inagaki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Atae Utsunomiya; Hiroshi Inagaki; Shinsuke Iida

  [Rinsho ketsueki] The Japanese journal of clinical hematology 56 11 2295 - 304 2015年11月 [査読有り]
  
• Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma

  Ayako Masaki; Takashi Ishida; Yasuhiro Maeda; Susumu Suzuki; Asahi Ito; Hisashi Takino; Hiroka Ogura; Haruhito Totani; Takashi Yoshida; Shiori Kinoshita; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Atsushi Inagaki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Atae Utsunomiya; Hiroshi Inagaki; Shinsuke Iida

  CLINICAL CANCER RESEARCH 21 12 2830 - 2839 2015年06月 [査読有り]
  
• Transplant-related mortality following allogeneic hematopoietic stem cell transplantation using fludarabine/busulfan-based reduced-intensity conditioning - A retrospective analysis in a single institution

  Takashi Yoshida; Shigeru Kusumoto; Arisa Masuda; Haruhito Totani; Tomoko Narita; Ayako Masaki; Asahi Ito; Masaki Ri; Takashi Ishida; Hirokazu Komatsu; Shinsuke Iida

  Japanese Journal of Cancer and Chemotherapy 42 6 719 - 724 2015年06月 [査読有り]
  
• t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.

  Narita T; Inagaki A; Kobayashi T; Kuroda Y; Fukushima T; Nezu M; Fuchida S; Sakai H; Sekiguchi N; Sugiura I; Maeda Y; Takamatsu H; Tsukamoto N; Maruyama D; Kubota Y; Kojima M; Sunami K; Ono T; Ri M; Tobinai K; Iida S

  Blood cancer journal 5 e285  2015年02月 [査読有り]
  
• OVEREXPRESSION OF SALIVARY-TYPE AMYLASE REDUCES THE SENSITIVITY TO BORTEZOMIB IN MULTIPLE MYELOMA CELLS

  Mizuno S; Hanamura I; Ota A; Karnan S; Narita T; Ri M; Goto M; Gotou M; Tsunekawa N; Shikami M; Iida S; Hosokawa Y; Miwa H; Ueda R; Masakazu N; Takami A

  HAEMATOLOGICA 100 1 249 - 250 2015年 [査読有り]
  
• Amylase-Producing Myeloma Cells Reduced Sensitivity to Dexamethasone and Bortezomib.

  Mizuno Shohei; Hanamura Ichiro; Ota Akinobu; Sivasundaram Karnan; Narita Tomoko; Ri Masaki; Mizutani Motonori; Goto Mineaki; Gotou Mayuko; Tsunekawa Norikazu; Shikami Masato; Iida Shinsuke; Hosokawa Yoshitaka; Miwa Hiroshi; Ueda Ryuzo; Nitta Masakazu; Takami Akiyoshi

  BLOOD 124 21 2014年12月 [査読有り]
  
• Amylaseを形質移入した骨髄腫細胞株の確立とその特徴(Establishment and characterization of myeloma cell lines transfected with amylase)

  Mizuno Shohei; Hanamura Ichiro; Ota Akinobu; Sivasundaram Karnan; Narita Tomoko; Ri Masaki; Goto Mineaki; Gotou Mayuko; Tsunekawa Norikazu; Shikami Masato; Iida Shinsuke; Hosokawa Yoshitaka; Miwa Hiroshi; Ueda Ryuzou; Nitta Masakazu; Takami Akiyoshi

  臨床血液 55 9 1306 - 1306 2014年09月
• Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model

  Fumiko Mori; Takashi Ishida; Asahi Ito; Fumihiko Sato; Ayako Masaki; Tomoko Narita; Susumu Suzuki; Tomiko Yamada; Hisashi Takino; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Masakatsu Hishizawa; Kazunori Imada; Akifumi Takaori-Kondo; Akio Niimi; Ryuzo Ueda; Hiroshi Inagaki; Shinsuke Iida

  EUROPEAN JOURNAL OF HAEMATOLOGY 92 3 219 - 228 2014年03月 [査読有り]
  
• HTLV-1 bZIP Factor-Specific CD4 T Cell Responses in Adult T Cell Leukemia/Lymphoma Patients after Allogeneic Hematopoietic Stem Cell Transplantation

  Tomoko Narita; Takashi Ishida; Ayako Masaki; Susumu Suzuki; Asahi Ito; Fumiko Mori; Tomiko Yamada; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuhiko Miyazaki; Yoshifusa Takatsuka; Atae Utsunomiya; Akio Niimi; Shinsuke Iida; Ryuzo Ueda

  JOURNAL OF IMMUNOLOGY 192 3 940 - 947 2014年02月 [査読有り]
  
• Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.

  Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R

  Journal of immunology (Baltimore, Md. : 1950) 191 1 135 - 144 2013年07月 [査読有り]
  
• [Sustained remission with allogeneic peripheral blood stem cell transplantation and subsequent maintenance therapy with dasatinib in a patient with myeloblastic crisis of imatinib-resistant CML].

  Narita T; Kayukawa S; Yoshida T; Kusumoto S; Kataoka T

  [Rinsho ketsueki] The Japanese journal of clinical hematology 54 3 279 - 283 The Japanese Society of Hematology 2013年03月 [査読有り]
  
• Angioimmunoblastic T-cell lymphoma mice model

  Fumihiko Sato; Takashi Ishida; Asahi Ito; Fumiko Mori; Ayako Masaki; Hisashi Takino; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Susumu Suzuki; Hirokazu Komatsu; Akio Niimi; Ryuzo Ueda; Hiroshi Inagaki; Shinsuke Iida

  LEUKEMIA RESEARCH 37 1 21 - 27 2013年01月 [査読有り]
  
• Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma

  Susumu Suzuki; Ayako Masaki; Takashi Ishida; Asahi Ito; Fumiko Mori; Fumihiko Sato; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuo Fukumori; Hiroyoshi Nishikawa; Yuetsu Tanaka; Akio Niimi; Hiroshi Inagaki; Shinsuke Iida; Ryuzo Ueda

  CANCER SCIENCE 103 10 1764 - 1773 2012年10月 [査読有り]
  
• Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma

  Susumu Suzuki; Ayako Masaki; Takashi Ishida; Asahi Ito; Fumiko Mori; Fumihiko Sato; Tomoko Narita; Masaki Ri; Shigeru Kusumoto; Hirokazu Komatsu; Yasuo Fukumori; Hiroyoshi Nishikawa; Yuetsu Tanaka; Akio Niimi; Hiroshi Inagaki; Shinsuke Iida; Ryuzo Ueda

  Cancer Science 103 10 1764 - 1773 2012年10月 [査読有り]
  
• Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.

  Ri M; Tashiro E; Oikawa D; Shinjo S; Tokuda M; Yokouchi Y; Narita T; Masaki A; Ito A; Ding J; Kusumoto S; Ishida T; Komatsu H; Shiotsu Y; Ueda R; Iwawaki T; Imoto M; Iida S

  Blood Cancer J. 2012年 [査読有り]
  

MISC

• The Abnormal Repression of Mir-375 Expression By Overlapping Epigenetic Dysregulations in Myelomas

  Shotaro Tatekawa; Yoshiaki Chinen; Yuji Shimura; Yayoi Matsumura-Kimoto; Hisao Nagoshi; Tsutomu Kobayashi; Eri Kawata; Tomoko Narita; Masaki Ri; Hiroshi Handa; Nobuhiko Uoshima; Shinsuke Iida; Junya Kuroda BLOOD 128 (22) 2016年12月
• Identification of Circulating Serum microRNAs As Novel Biomarkers Predicting Disease Progression and Sensitivity to Bortezomib Treatment in Multiple Myeloma

  Tomoko Narita; Masaki Ri; Shiori Kinoshita; Takashi Yoshida; Haruhito Totani; Reham Ashour; Ayako Masaki; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Makoto Osabe; Masahiro Tohkin; Shinsuke Iida BLOOD 128 (22) 2016年12月
• 多発性骨髄腫に合併したアミロイドーシスの皮膚生検での診断と危険因子における統計学的考察

  的屋 真美; 加藤 裕史; 春本 真以; 村松 伸之介; 西田 絵美; 楠本 茂; 李 政樹; 成田 朋子; 森田 明理 日本皮膚科学会雑誌 126 (5) 950 -950 2016年05月
• 多発性骨髄腫におけるmiR-375のエピジェネティック異常によるPDPK1発現亢進

  立川 章太郎; 知念 良顕; 志村 勇司; 名越 久朗; 古林 勉; 木元 弥生; 河田 英里; 成田 朋子; 李 政樹; 半田 寛; 魚嶋 伸彦; 飯田 真介; 黒田 純也 International Journal of Myeloma 6 (2) 64 -64 2016年04月
• 多発性骨髄腫におけるmiR-375のエピジェネティック異常によるPDPK1発現亢進

  立川 章太郎; 知念 良顕; 志村 勇司; 名越 久朗; 古林 勉; 木元 弥生; 河田 英里; 成田 朋子; 李 政樹; 半田 寛; 魚嶋 伸彦; 飯田 真介; 黒田 純也 International Journal of Myeloma 6 (2) 76 -76 2016年04月
• 多発性骨髄腫の治療方針に必要な染色体・遺伝子検査 (特集 血液疾患の治療前必須検査とその解釈)

  成田 朋子; 李 政樹 血液内科 = Hematology 70 (5) 581 -584 2015年05月
• Chromosomal Translocation (14;16)-Positive Multiple Myeloma Shows Negativity for CD56 Expression and Unfavorable Outcome Even in the Era of Novel Drugs

  Tomoko Narita; Atsushi Inagaki; Tsutomu Kobayashi; Yoshiaki Kuroda; Toshihiro Fukushima; Masahiko Nezu; Shin-ichi Fuchida; Hirotaka Sakai; Naohiro Sekiguchi; Isamu Sugiura; Yoshinobu Maeda; Hiroyuki Takamatsu; Norifumi Tsukamoto; Dai Maruyama; Yasushi Kubota; Minoru Kojima; Kazutaka Sunami; Takaaki Ono; Masaki Ri; Kensei Tobinai; Shinsuke Iida BLOOD 124 (21) 2014年12月
• MM細胞株を用いた異所性アミラーゼ安定的発現株の樹立とその性状解析

  水野昌平; 花村一朗; 太田明伸; SIVASUNDARAM Karnan; 成田朋子; 李政樹; 後藤峰明; 後藤麻友子; 恒川敬和; 爾見雅人; 飯田真介; 細川好孝; 上田龍三; 仁田正和; 三輪啓志 Int J Myeloma (Web) 4 (2) O-1 (WEB ONLY) 2014年
• 再発・治療抵抗性多発性骨髄腫に対する次世代プロテアソーム阻害薬carfilzomibの第Ⅱ相試験 (特集 血液腫瘍に対する重要な臨床試験と国内外の診療に及ぼすインパクト)

  成田 朋子; 楠本 茂 血液内科 66 (4) 474 -480 2013年04月
• Reduced Expression of HDAC3 Contributes to the Resistance Against HDAC Inhibitor, Vorinostat (SAHA) in Mature Lymphoid Malignancies

  Jianming (Diane) Ding; Masaki Ri; Tomoko Narita; Ayako Masaki; Fumiko Mori; Asahi Ito; Shigeru Kusumoto; Takashi Ishida; Hirokazu Komatsu; Yukimasa Shiotsu; Akio Niimi; Shinsuke Iida BLOOD 120 (21) 2012年11月

その他のリンク

researchmap

https://researchmap.jp/naritomo